Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Evidence on VNS in the Modern DRE Treatment Landscape
13
Mins
August 2025
Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…
Read more
9 Dec 2014
New Approaches to Meet Patients’ Needs in Clinical Practice
Migraine is a primary headache disorder affecting up to four in ten women and up to two in ten men, mostly before the age of 35 years.1 By the age of 30…
14 Jul 2014
Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease
This educational symposium was held during the Joint Congress of European Neurology (EFNS–ENS), which took place from 31st May to 3rd June 2014 in…
14 Jul 2014
The Evolving Ms Landscape: Challenges and Opportunities
Historically, multiple sclerosis (MS) treatment goals have focused on clinical endpoints, delaying disability, and reducing relapse frequency, and…
14 Jul 2014
Paradigms: A New Initiative to Cut Through the Noise on Multiple Sclerosis a Conversation with Dr Andreas Lysandropoulos
ParadigMS is a new, independent peer-group of multiple sclerosis (MS) experts, aiming to provide a high level of science and insight to healthcare…
14 Jul 2014
Neuroimaging of Acute Ischaemic Stroke: Current Challenges
Over the last decade, neuroimaging methods have been refined to improve clinical decisions regarding acute stroke treatment. Computed tomography and…
14 Jul 2014
Depression and Psychological Distress as Risk Factors for Stroke and Worse Stroke Recovery: Clinical Implications and Therapeutic Options
Stroke and depression have a strong bidirectional association: on the one hand, depression and psychosocial distress are well known risk factors for…
14 Jul 2014
Imaging and Treatment Decisions in Seizures and Epilepsy
It has been clearly shown that magnetic resonance imaging (MRI) is the preferred modality of structural imaging for both new onset seizures and…
14 Jul 2014
A Scarlet Enemy of the Brain – A Practical Approach to Diagnosis and Management of Cerebral Amyloid Angiopathy
We present two cases of elderly patients admitted with neurological dysfunction due to isolated focal cortical subarachnoid bleeding and intracerebral…
Loading posts...
« Previous
1
…
19
20
21
22
23
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View